Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-05-15
2007-05-15
Fredman, Jeffrey (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100
Reexamination Certificate
active
11409216
ABSTRACT:
Aplasia of the corpus callosum or aspermatogenesis is diagnosed by investigating existence or expression of the BT-IgSF gene with use of a primer for PCR or probe for hybridization comprising a DNA coding for a novel cell adhesion molecule (BT-IgSF) defined in the following (A) or (B) or a partial sequence thereof:(A) a protein comprising the amino acid sequence of the amino acid numbers 1 to 409 of SEQ ID NO: 2;(B) a protein comprising an amino acid sequence of the amino acid numbers 1 to 409 of SEQ ID NO: 2 including substitution, deletion, insertion or addition of one or several amino acids and having a function as a cell adhesion molecule.
REFERENCES:
patent: 1 211 313 (2002-06-01), None
patent: 11-018622 (1999-01-01), None
patent: WO 98/45434 (1998-10-01), None
patent: WO 00/00604 (2000-01-01), None
patent: WO 01/54474 (2001-08-01), None
patent: WO 01/54708 (2001-08-01), None
patent: WO 01/55315 (2001-08-01), None
patent: WO 01/75067 (2001-10-01), None
XP-002234524, Jan. 10. 2002, Abstract (WO 0154474 A) (EBI Database Accession No. ABB10359).
XP-002234525, Nov. 7, 2001, Abstract (WO 0155315 A) (EBI Database Accession No. AAU18038).
XP-002234526, Oct. 8, 2001, Abstract (EBI Database Accession No. BI830026).
Geneseq Assession No. ABA06581 dated Jan. 10, 2002.
Geneseq Assession No. AAS28826, dated Nov. 7, 2001.
Geneseq Assession No. ABA06752, dated Jan. 10, 2002.
Geneseq Assession No. AAS28873, dated Nov. 7, 2001.
Geneseq Assession No. ABB10530, dated Jan. 10, 2002.
Geneseq Assession No. AAU18085, dated Nov. 7, 2001.
Geneseq Assession No. AAU18038, dated Nov. 7, 2001.
Geneseq Assession No. ABB10359, dated Jan. 10, 2002.
Geneseq Assession No. ABG16751, dated Feb. 18, 2002.
Fechner, et al. “Expression of Coxsackie Adenovirus Receptor and Alphav-integrin Does Not Correlate with Adenovector Targeting In Vivo Indicating Anatomical Vector Barriers,”Gene Therapy, vol. 6, No. 9, pp. 1520-1535, 1999.
Suzu, et al. Molecular Cloning of a Novel Immunoglobulin Superfamily Gene Preferentially Expressed by Brain and Testis,Biochemical and Biophysical research Communications, vol. 296, No. 5, pp. 1215-1221, 2002.
European Search Report, dated Mar. 13, 2003, corresponding to a related European patent application.
Cyr, et al. “Identification and Developmental Regulation of Cadherin Messenger Ribonucleic Acids in the Rat Testis,”Endocrinology. vol. 131, No. 1, pp. 139-145, 1992.
Genuardi, et al. “A New Case of Interstitial Deletion of Chromosome 3q, del(3q)(q13.12q21.3) with Agenesis of the Corpus Callosum,”Clinical Dysmorphology, vol. 3, pp. 292-296, 1994.
Kamiguchi, et al. “Adhesion Molecules and Inherited Diseases of the Human Nervous System,”Annual Review of Neuroscience, vol. 21, pp. 97-125, 1998.
Ogilvie, et al. “Deletion of Chromosome 3q Proximal Region Gives Rise to a Variable Phenotype,”Clinical Genetics, vol. 53, pp. 220-222, 1998.
Roche Diagnostics GmbH, Expand Long Template PCR System Jun. 2002.
Buck, et al. Design strategies and performance of custom DNA sequencing primers. Biotechniques. Sep. 1999; 27(3):528-36.
Ginzinger, DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol. Jun. 2002;30(6):503-12.
Kuromitsu, et al. A unique downregulation of h2-calponin gene expression in Down syndrome : a possible attenuation mechanism for fetal survival by methylation at the CpG island in the trisomic chromosome 21, Molecular and Cellular Biology, vol. 17, No. 2, pp. 707-712, Feb. 1997.
Hageshita Hiroaki
Hayasawa Hirotoshi
Nomaguchi Kouji
Suzu Shinya
Yamada Muneo
Fredman Jeffrey
Morinaga Milk Industry Co. Ltd.
Woolwine Samuel
LandOfFree
Method for diagnosing aplasia of corpus callosum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing aplasia of corpus callosum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing aplasia of corpus callosum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3799729